NAVLE Urinary

Canine Cystitis Study Guide

Bacterial cystitis is inflammation of the urinary bladder caused by bacterial infection. It represents one of the most common infectious diseases in dogs, affecting approximately 14% of dogs at some point during their lifetime.

Overview and Clinical Importance

Bacterial cystitis is inflammation of the urinary bladder caused by bacterial infection. It represents one of the most common infectious diseases in dogs, affecting approximately 14% of dogs at some point during their lifetime. Unlike cats, where most lower urinary tract disease is idiopathic and sterile, bacterial infection is the predominant cause of cystitis in dogs. This distinction is critical for the NAVLE, as it influences diagnostic and therapeutic approaches.

Cystitis typically arises from bacteria ascending from the perineum through the urethra to the bladder. Female dogs are at significantly higher risk due to their shorter, wider urethra compared to males. The urinary tract possesses multiple defense mechanisms against infection, including antimicrobial peptides in urine, high urine osmolality, the physical barrier of the urothelium, and normal voiding patterns that flush bacteria. Bacterial cystitis occurs when these host defenses are compromised.

Classification Definition Clinical Significance
Sporadic Bacterial Cystitis Fewer than 3 episodes within 12 months in otherwise healthy non-pregnant females or neutered males Short-course therapy (3-5 days) appropriate; culture not mandatory but preferred
Recurrent Bacterial Cystitis 3 or more episodes within 12 months, OR 2 or more within 6 months Requires investigation for underlying causes; culture mandatory; consider imaging
Subclinical Bacteriuria Positive urine culture WITHOUT clinical signs of urinary tract disease Treatment NOT recommended in most cases; may be protective
Pyelonephritis Bacterial infection of renal parenchyma Requires longer therapy (10-14 days); fluoroquinolones first-line; tissue levels important

Classification of Bacterial Urinary Tract Disease

Understanding the classification of bacterial urinary tract disease is essential for appropriate diagnosis and management. The 2019 ISCAID guidelines provide standardized definitions that have replaced older terminology such as "simple" and "complicated" UTI.

High-YieldSubclinical bacteriuria does NOT require treatment in most dogs. Up to 8.9% of healthy female dogs have subclinical bacteriuria that may actually be protective against colonization by more pathogenic bacteria. Treating subclinical bacteriuria promotes antimicrobial resistance without clinical benefit.
Organism Prevalence Clinical Significance
Escherichia coli 50-70% Most common; gram-negative rod; responds to most first-line antimicrobials
Staphylococcus spp. 10-15% Gram-positive cocci; urease-producing strains can cause struvite urolithiasis
Proteus mirabilis 8-11% Urease-producing; causes alkaline urine pH; strongly associated with struvite stones
Enterococcus spp. 3-5% Intrinsically resistant to cephalosporins; often requires amoxicillin or ampicillin
Klebsiella spp. 2-5% Intrinsically resistant to amoxicillin; some strains urease-producing
Pseudomonas spp. 1-3% Multi-drug resistant; often requires fluoroquinolones; associated with complicated UTIs

Etiology and Pathogenesis

Common Bacterial Pathogens

Most cases of bacterial cystitis in dogs are caused by a single organism. Escherichia coli is the most commonly isolated pathogen, accounting for approximately 50-70% of all canine UTIs. Understanding the typical pathogens guides empirical therapy selection.

NAVLE TipWhen you see struvite crystalluria with alkaline urine pH and cocci on sediment, think urease-producing bacteria (Staphylococcus, Proteus). These organisms convert urea to ammonia, alkalinizing the urine and promoting struvite (magnesium ammonium phosphate) precipitation. The NAVLE frequently tests this association!

Host Defense Mechanisms

The urinary tract possesses multiple defense mechanisms that must be breached for infection to occur:

  • Antimicrobial peptides: Present in urine; prevent bacterial adherence and proliferation on the urothelium
  • High urine osmolality: Concentrated urine creates hostile environment for bacterial growth
  • Urothelial barrier: Glycosaminoglycan layer and tight junctions prevent bacterial attachment
  • Normal voiding: Regular, complete bladder emptying flushes bacteria before colonization
  • Immune response: Local and systemic immune mechanisms eliminate invading pathogens
Clinical Sign Description and Clinical Relevance
Pollakiuria Increased frequency of urination; most common presenting sign; results from bladder inflammation triggering urge to void
Dysuria/Stranguria Painful or difficult urination; straining to urinate; often mistaken for constipation by owners
Hematuria Blood in urine; may be gross (visible) or microscopic; occurs from mucosal inflammation and ulceration
Malodorous urine Strong or foul-smelling urine; results from bacterial metabolism
Periuria Inappropriate urination; house-trained dogs urinating indoors; due to urgency

Clinical Presentation

Classic Clinical Signs

The classic triad of lower urinary tract disease includes pollakiuria, stranguria/dysuria, and hematuria. However, these signs are NOT pathognomonic for bacterial infection and can occur with any cause of bladder inflammation.

Physical Examination Findings

Physical examination findings are often unremarkable in uncomplicated bacterial cystitis. Important findings to assess include:

  • Bladder palpation: May reveal thickened bladder wall; bladder often small due to frequent voiding; pain on palpation
  • Vulvar examination (females): Assess for recessed vulva, perivulvar dermatitis, or vaginal discharge
  • Rectal examination (intact males): Evaluate prostate for size, symmetry, and pain; prostatic involvement = complicated UTI
  • Systemic signs: Fever, lethargy, anorexia suggest pyelonephritis or sepsis; require more aggressive workup
High-YieldIntact male dogs with UTI should ALWAYS have prostatic evaluation. The prostate is considered an extension of the urinary tract, and prostatic involvement automatically classifies the infection as complicated, requiring longer treatment (4-6 weeks) with antimicrobials that penetrate the blood-prostate barrier (fluoroquinolones, TMS, chloramphenicol).
Finding Definition Interpretation
Pyuria Greater than 5 WBC/hpf Indicates inflammation; supports infection but NOT pathognomonic; can occur with sterile inflammation
Bacteriuria Bacteria visible on sediment examination Highly predictive of positive culture in cystocentesis samples; rods easier to identify than cocci
Hematuria Greater than 5 RBC/hpf Nonspecific; occurs with infection, stones, trauma, neoplasia; mild hematuria may be iatrogenic from cystocentesis
Alkaline pH Urine pH greater than 7.5 Suggests urease-producing bacteria (Staphylococcus, Proteus); associated with struvite urolithiasis
Proteinuria Positive protein on dipstick Often present with inflammation; interpret with pH and USG; false positives with alkaline or concentrated urine

Diagnostic Approach

Urinalysis

Complete urinalysis is the cornerstone of UTI diagnosis. It should include urine specific gravity, dipstick analysis, and microscopic sediment examination. Cystocentesis is the preferred collection method as it prevents contamination and allows meaningful interpretation of culture results.

Exam Focus: The leukocyte esterase and nitrite pads on urine dipsticks are INACCURATE in dogs and cats! Never use these for UTI diagnosis in veterinary patients. Only pyuria on sediment examination and urine culture are reliable for diagnosis.

Urine Culture and Sensitivity

Quantitative aerobic urine culture is the gold standard for diagnosis of bacterial cystitis. It confirms infection, identifies the pathogen, and guides antimicrobial selection through sensitivity testing.

Diagnostic Imaging

Imaging is not required for sporadic bacterial cystitis but becomes essential for recurrent infections to identify underlying causes.

Ultrasonography

Ultrasonography provides excellent evaluation of bladder wall thickness, masses, and calculi. Key findings in cystitis include:

  • Wall thickening: Normal canine bladder wall is less than 3 mm with adequate distension; thickening suggests chronic inflammation
  • Mucosal irregularity: Loss of smooth inner surface; most pronounced cranioventrally in chronic cystitis
  • Echogenic debris: Cellular debris or blood clots in bladder lumen
  • Calculi: Hyperechoic structures with acoustic shadowing (regardless of composition)

Radiography

Radiography is useful for detecting radiopaque uroliths and identifying complications such as emphysematous cystitis. Contrast studies (cystography) may be needed for radiolucent stones, masses, or anatomical abnormalities not visible on survey radiographs.

Collection Method Significant Growth Interpretation
Cystocentesis Greater than 1,000 CFU/mL ANY growth significant as bladder urine should be sterile
Catheterization Greater than 10,000 CFU/mL Higher threshold due to urethral contamination
Voided/Free-catch Greater than 100,000 CFU/mL High risk of contamination; refrigerate and process quickly

Special Forms of Cystitis

Emphysematous Cystitis

Emphysematous cystitis is characterized by gas accumulation within the bladder wall and/or lumen due to infection with glucose-fermenting bacteria. It is most commonly associated with diabetes mellitus due to the high concentration of fermentable substrate (glucose) in urine. E. coli is the most common causative organism, though Proteus, Klebsiella, and Clostridium species have also been reported.

Imaging findings: On radiography, mottled gas opacities appear within the bladder wall (intramural gas) or free gas within the lumen. On ultrasonography, hyperechoic foci with reverberation artifacts are seen. Ultrasound is more sensitive for detecting early or small amounts of gas.

NAVLE TipWhen you see gas in the bladder wall on radiographs + diabetic patient, think emphysematous cystitis! Treatment includes appropriate antimicrobials for complicated UTI (minimum 4 weeks), management of underlying diabetes, and careful cystocentesis (bladder wall integrity may be compromised). Prognosis is generally good with appropriate treatment.

Polypoid Cystitis

Polypoid cystitis is characterized by benign epithelial proliferations (polyps) projecting into the bladder lumen, typically located cranioventrally. It results from chronic inflammation, often associated with recurrent UTIs, urolithiasis, or chronic catheterization. The condition must be differentiated from transitional cell carcinoma (TCC) through histopathology.

Key differentiating features from TCC:

  • Location: Polypoid cystitis is cranioventral; TCC has predilection for trigone
  • Appearance: Polyps are often pedunculated; TCC has broad-based attachment
  • Definitive diagnosis: ALWAYS requires histopathology via cystoscopy or suction biopsy
Drug Dosage Duration Notes
Amoxicillin (First-line) 11-15 mg/kg PO q8-12h 3-5 days High urine concentrations; good first-line choice; Klebsiella resistant
Amoxicillin-Clavulanate 12.5-25 mg/kg PO q8-12h 3-5 days Acceptable if amoxicillin unavailable; clavulanate may not be necessary for cystitis
TMS (First-line) 15 mg/kg PO q12h 3-5 days Rare adverse effects with short courses; avoid in KCS-prone breeds with long-term use
Fluoroquinolones Variable by drug Reserve NOT first-line for cystitis; reserve for pyelonephritis or documented resistant infections

Treatment Guidelines (ISCAID 2019)

Sporadic Bacterial Cystitis

The 2019 ISCAID guidelines recommend short-course antimicrobial therapy (3-5 days) for sporadic bacterial cystitis. This represents a significant change from previous recommendations of 10-14 days and is based on evidence that short courses are equally effective while reducing antimicrobial exposure.

Recurrent and Complicated Infections

Recurrent and complicated infections require a different approach with extended treatment duration and thorough investigation for underlying causes.

Supportive Therapy

NSAIDs can provide analgesia while awaiting culture results or as adjunctive therapy. Always verify renal function before use. Increased water intake to promote urinary dilution and frequent voiding can help flush bacteria from the urinary tract.

Condition Treatment Duration Additional Considerations
Recurrent Cystitis 7-14 days (based on clinical response) Culture mandatory; investigate for underlying causes; consider imaging
Pyelonephritis 10-14 days Fluoroquinolones first-line; tissue levels important; monitor renal values
Prostatitis (intact males) 4-6 weeks Use drugs that penetrate blood-prostate barrier: fluoroquinolones, TMS, chloramphenicol
Emphysematous Cystitis Minimum 4 weeks Treat underlying diabetes; culture mandatory; monitor with imaging

Predisposing Factors and Comorbidities

Identification of underlying conditions is essential for managing recurrent UTIs. These comorbidities must be addressed for successful treatment.

Comorbidity Mechanism and Management
Diabetes Mellitus Glucosuria provides substrate for bacterial growth; immunosuppression; may cause emphysematous cystitis. Optimize glycemic control.
Hyperadrenocorticism Immunosuppression and dilute urine from PU/PD. 50% of Cushingoid dogs have UTI. Treat underlying Cushing's.
Chronic Kidney Disease Dilute urine reduces antimicrobial activity; uremic immunosuppression. Consider drug dosing adjustments.
Urolithiasis Stones provide nidus for bacterial colonization; struvite stones often infection-induced. Remove or dissolve stones.
Anatomic Abnormalities Ectopic ureters, urachal remnants, recessed vulva, bladder diverticula. May require surgical correction.
Neurologic Bladder Dysfunction Incomplete voiding allows bacterial colonization (IVDD, cauda equina). May require intermittent catheterization.
Immunosuppressive Therapy Corticosteroids, chemotherapy compromise host defenses. Monitor for UTI; screen routinely in high-risk patients.

Monitoring and Follow-up

Sporadic Cystitis

For sporadic bacterial cystitis, routine post-treatment urinalysis or culture is NOT indicated if clinical signs resolve. Owners should monitor for resolution of clinical signs, which typically occurs within 48-72 hours. Recheck only if signs persist or recur.

Recurrent/Complicated Infections

For complicated infections, perform urine culture:

  • 5-7 days after starting treatment (to confirm appropriate therapy)
  • 7-14 days after completing treatment (to confirm cure)
  • 1-3 months post-treatment for monitoring in high-risk patients

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →